Evogene Ltd. (TLV:EVGN)
478.00
+1.20 (0.25%)
Apr 1, 2025, 4:38 PM IDT
Evogene Revenue
In the year 2024, Evogene had annual revenue of $8.51M USD with 50.90% growth. Evogene had revenue of $1.61M in the quarter ending December 31, 2024, with 178.72% growth.
Revenue
$8.51M
Revenue Growth
+50.90%
P/S Ratio
0.87
Revenue / Employee
$72.74K
Employees
117
Market Cap
30.71M ILS
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 8.51M | 2.87M | 50.90% |
Dec 31, 2023 | 5.64M | 3.97M | 236.72% |
Dec 31, 2022 | 1.68M | 745.00K | 80.11% |
Dec 31, 2021 | 930.00K | -110.00K | -10.58% |
Dec 31, 2020 | 1.04M | 287.00K | 38.11% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Teva Pharmaceutical Industries | 60.26B |
Danel (Adir Yeoshua) | 2.77B |
Kamada | 586.24M |
Bait Bakfar | 103.40M |
Novolog (Pharm-Up 1966) | 2.02B |
Ilex Medical | 982.96M |
BrainsWay | 149.39M |
SofWave Medical | 217.27M |
Evogene News
- 26 days ago - Evogene Ltd. (EVGN) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 26 days ago - Evogene GAAP EPS of -$0.06 beats by $0.66, revenue of $1.61M misses by $2.02M - Seeking Alpha
- 26 days ago - Evogene appoints Nir Nimrodi as new chair - Seeking Alpha
- 26 days ago - Evogene Reports Fourth Quarter and Full Year 2024 Financial Results - PRNewsWire
- 26 days ago - Evogene Announces the Appointment of Nir Nimrodi as the New Chairperson of the Board, Effective March 5, 2025 - PRNewsWire
- 26 days ago - Earnings Scheduled For March 6, 2025 - Benzinga
- 27 days ago - Evogene Q4 2024 Earnings Preview - Seeking Alpha
- 5 weeks ago - Evogene Schedules Fourth Quarter 2024 Financial Results Release - PRNewsWire